US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market

ID: MRFR/MED/52348-HCR
200 Pages
Rahul Gotadki
Last Updated: July 02, 2026
US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market Research Report By Diagnosis (Microbiological Culture Test, Polymerase Chain Reaction, Imaging Studies), By Treatment (Antibiotics, Antimicrobial Therapy, Surgery), and By End-user (Hospitals, Ambulatory Surgery Centers, Others) - Growth & Industry Forecast 2025 To 2035
US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.43%
2023 Market Size$ 504.53 Million
2024 Market Size$ 1,250 Million
2035 Market Size$ 2,750 Million
Key Players
Siemens Healthineers
Abbott Laboratories
Stryker Corporation
MediWound
BD
Roche
Opportunities
  • Regulatory Support and Guidelines
  • Advancements in Diagnostic Technologies
  • Growing Awareness and Preventive Measures
  1. TABLE OF CONTENTS1. EXECUTIVE SUMMARY
    1. 1.1 Market Overview
    2. 1.2 Key Findings
    3. 1.3 Market Segmentation
    4. 1.4 Competitive Landscape
    5. 1.5 Challenges and Opportunities
    6. 1.6 Future Outlook
  2. 2 MARKET INTRODUCTION
    1. 2.1 Definition
    2. 2.2 Scope of the study
      1. 2.2.1 Research Objective
      2. 2.2.2 Assumption
      3. 2.2.3 Limitations
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 Overview
    2. 3.2 Data Mining
    3. 3.3 Secondary Research
    4. 3.4 Primary Research
      1. 3.4.1 Primary Interviews and Information Gathering Process
      2. 3.4.2 Breakdown of Primary Respondents
    5. 3.5 Forecasting Model
    6. 3.6 Market Size Estimation
      1. 3.6.1 Bottom-Up Approach
      2. 3.6.2 Top-Down Approach
    7. 3.7 Data Triangulation
    8. 3.8 Validation
  4. 4 MARKET DYNAMICS
    1. 4.1 Overview
    2. 4.2 Drivers
    3. 4.3 Restraints
    4. 4.4 Opportunities5. MARKET FACTOR ANALYSIS
    5. 5.1 Value chain Analysis
    6. 5.2 Porter's Five Forces Analysis
      1. 5.2.1 Bargaining Power of Suppliers
      2. 5.2.2 Bargaining Power of Buyers
      3. 5.2.3 Threat of New Entrants
      4. 5.2.4 Threat of Substitutes
      5. 5.2.5 Intensity of Rivalry
    7. 5.3 COVID-19 Impact Analysis
      1. 5.3.1 Market Impact Analysis
      2. 5.3.2 Regional Impact
      3. 5.3.3 Opportunity and Threat Analysis
  5. 6 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY DIAGNOSIS (USD MILLION)
    1. 6.1 Microbiological Culture Test
    2. 6.2 Polymerase Chain Reaction
    3. 6.3 Imaging Studies7. US STAPHYLOCOCCUS AUREUS US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY TREATMENT (USD MILLION)
    4. 7.1 Antibiotics
    5. 7.2 Antimicrobial Therapy
    6. 7.3 Surgery8. US STAPHYLOCOCCUS AUREUS US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY END USER (USD MILLION)
    7. 8.1 Hospitals
    8. 8.2 Ambulatory Surgery Centers
    9. 8.3 Others
  6. 9 COMPETITIVE LANDSCAPE
    1. 9.1 Overview
    2. 9.2 Competitive Analysis
    3. 9.3 Market share Analysis
    4. 9.4 Major Growth Strategy in the Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market
    5. 9.5 Competitive Benchmarking
    6. 9.6 Leading Players in Terms of Number of Developments in the Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market
    7. 9.7 Key developments and growth strategies
      1. 9.7.1 New Product Launch/Service Deployment
      2. 9.7.2 Merger & Acquisitions
      3. 9.7.3 Joint Ventures
    8. 9.8 Major Players Financial Matrix
      1. 9.8.1 Sales and Operating Income
      2. 9.8.2 Major Players R&D Expenditure.
  7. 202310 COMPANY PROFILES
    1. 10.1 Siemens Healthineers
      1. 10.1.1 Financial Overview
      2. 10.1.2 Products Offered
      3. 10.1.3 Key Developments
      4. 10.1.4 SWOT Analysis
      5. 10.1.5 Key Strategies
    2. 10.2 Abbott Laboratories
      1. 10.2.1 Financial Overview
      2. 10.2.2 Products Offered
      3. 10.2.3 Key Developments
      4. 10.2.4 SWOT Analysis
      5. 10.2.5 Key Strategies
    3. 10.3 Stryker Corporation
      1. 10.3.1 Financial Overview
      2. 10.3.2 Products Offered
      3. 10.3.3 Key Developments
      4. 10.3.4 SWOT Analysis
      5. 10.3.5 Key Strategies
    4. 10.4 MediWound
      1. 10.4.1 Financial Overview
      2. 10.4.2 Products Offered
      3. 10.4.3 Key Developments
      4. 10.4.4 SWOT Analysis
      5. 10.4.5 Key Strategies
    5. 10.5 BD
      1. 10.5.1 Financial Overview
      2. 10.5.2 Products Offered
      3. 10.5.3 Key Developments
      4. 10.5.4 SWOT Analysis
      5. 10.5.5 Key Strategies
    6. 10.6 Roche
      1. 10.6.1 Financial Overview
      2. 10.6.2 Products Offered
      3. 10.6.3 Key Developments
      4. 10.6.4 SWOT Analysis
      5. 10.6.5 Key Strategies
    7. 10.7 Molecular Diagnostics
      1. 10.7.1 Financial Overview
      2. 10.7.2 Products Offered
      3. 10.7.3 Key Developments
      4. 10.7.4 SWOT Analysis
      5. 10.7.5 Key Strategies
    8. 10.8 Ortho Clinical Diagnostics
      1. 10.8.1 Financial Overview
      2. 10.8.2 Products Offered
      3. 10.8.3 Key Developments
      4. 10.8.4 SWOT Analysis
      5. 10.8.5 Key Strategies
    9. 10.9 Johnson & Johnson
      1. 10.9.1 Financial Overview
      2. 10.9.2 Products Offered
      3. 10.9.3 Key Developments
      4. 10.9.4 SWOT Analysis
      5. 10.9.5 Key Strategies
    10. 10.10 Thermo Fisher Scientific
      1. 10.10.1 Financial Overview
      2. 10.10.2 Products Offered
      3. 10.10.3 Key Developments
      4. 10.10.4 SWOT Analysis
      5. 10.10.5 Key Strategies
    11. 10.11 Medtronic
      1. 10.11.1 Financial Overview
      2. 10.11.2 Products Offered
      3. 10.11.3 Key Developments
      4. 10.11.4 SWOT Analysis
      5. 10.11.5 Key Strategies
    12. 10.12 BioMérieux
      1. 10.12.1 Financial Overview
      2. 10.12.2 Products Offered
      3. 10.12.3 Key Developments
      4. 10.12.4 SWOT Analysis
      5. 10.12.5 Key Strategies
    13. 10.13 Hologic
      1. 10.13.1 Financial Overview
      2. 10.13.2 Products Offered
      3. 10.13.3 Key Developments
      4. 10.13.4 SWOT Analysis
      5. 10.13.5 Key Strategies
    14. 10.14 Cepheid
      1. 10.14.1 Financial Overview
      2. 10.14.2 Products Offered
      3. 10.14.3 Key Developments
      4. 10.14.4 SWOT Analysis
      5. 10.14.5 Key Strategies
    15. 10.15 Becton Dickinson
      1. 10.15.1 Financial Overview
      2. 10.15.2 Products Offered
      3. 10.15.3 Key Developments
      4. 10.15.4 SWOT Analysis
      5. 10.15.5 Key Strategies11. APPENDIX
    16. 11.1 References
    17. 11.2 Related ReportsLIST OF TABLESTABLE
  8. 1 LIST OF ASSUMPTIONS
    1. TABLE
  9. 2 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SIZE ESTIMATES & US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY DIAGNOSIS, 2019-2035 (USD BILLIONS)
    1. TABLE
  10. 3 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SIZE ESTIMATES & US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY TREATMENT, 2019-2035 (USD BILLIONS)
    1. TABLE
  11. 4 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SIZE ESTIMATES & US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY END USER, 2019-2035 (USD BILLIONS)
    1. TABLE
  12. 5 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    1. TABLE
  13. 6 ACQUISITION/PARTNERSHIP LIST OF FIGURESFIGURE
  14. 1 MARKET SYNOPSIS
    1. FIGURE
  15. 2 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET ANALYSIS BY DIAGNOSIS
    1. FIGURE
  16. 3 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET ANALYSIS BY TREATMENT
    1. FIGURE
  17. 4 US STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET ANALYSIS BY END USER
    1. FIGURE
  18. 5 KEY BUYING CRITERIA OF STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
    1. FIGURE
  19. 6 RESEARCH PROCESS OF MRFR
    1. FIGURE
  20. 7 DRO ANALYSIS OF STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
    1. FIGURE
  21. 8 DRIVERS IMPACT ANALYSIS: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
    1. FIGURE
  22. 9 RESTRAINTS IMPACT ANALYSIS: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
    1. FIGURE
  23. 10 SUPPLY / VALUE CHAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
    1. FIGURE
  24. 11 STAPHYLOCOCCUS US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY DIAGNOSIS, 2025 (% SHARE)
    1. FIGURE
  25. 12 STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY DIAGNOSIS, 2019 TO 2035 (USD Billions)
    1. FIGURE
  26. 13 US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY TREATMENT, 2025 (% SHARE)
    1. FIGURE
  27. 14 STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY TREATMENT, 2019 TO 2035 (USD Billions)
    1. FIGURE
  28. 15 STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS TREATMENT FOR ORTHOPEDIC IMPLANT US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY END USER, 2025 (% SHARE)
    1. FIGURE
  29. 16 STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market, BY END USER, 2019 TO 2035 (USD Billions)
    1. FIGURE
  30. 17 BENCHMARKING OF MAJOR COMPETITORS

US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market Segmentation

 

  • US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market By Diagnosis (USD Million, 2019-2035)
    • Microbiological Culture Test
    • Polymerase Chain Reaction
    • Imaging Studies
  • US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market By Treatment (USD Million, 2019-2035)
    • Antibiotics
    • Antimicrobial Therapy
    • Surgery
  • US Staphylococcus aureus Infection Diagnosis Treatment for Orthopedic Implant Market By End User (USD Million, 2019-2035)
    • Hospitals
    • Ambulatory Surgery Centers
    • Others
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.